Pharmaceuticals · 2013 · 20 citations · 29 references
PharmacyMedicinal ChemistryOncologyCancer PharmacologyDrug DeliveryTargeted Drug DeliveryCell-penetrating PeptidesPeptide ChemistryPeptide DeliveryProtein DeliveryProtein TargetingVenom BiologyCationic PeptidesCell Penetration MechanismsHydrophobic PeptidesPeptide Permeability EnhancementPeptide-based TargetingPh-triggered Cell PenetrationTargeting PeptidesTumor-targeting Peptides
Maurocalcine is a highly potent cell-penetrating peptide isolated from the Tunisian scorpion Maurus palmatus. Many cell-penetrating peptide analogues have been derived from the full-length maurocalcine by internal cysteine substitutions and sequence truncation. Herein we have further characterized the cell-penetrating properties of one such peptide, MCaUF1-9, whose sequence matches that of the hydrophobic face of maurocalcine. This peptide shows very favorable cell-penetration efficacy compared to Tat, penetratin or polyarginine. The peptide appears so specialized in cell penetration that it seems hard to improve by site directed mutagenesis. A comparative analysis of the efficacies of similar peptides isolated from other toxin members of the same family leads to the identification of hadrucalcin's hydrophobic face as an even better CPP. Protonation of the histidine residue at position 6 renders the cell penetration of MCaUF1-9 pH-sensitive. Greater cell penetration at acidic pH suggests that MCaUF1-9 can be used to specifically target cancer cells in vivo where tumor masses grow in more acidic environments.
29
Regions of the skeletal muscle dihydropyridine receptor critical for excitation–contraction coupling
Tsutomu Tanabe, Kurt G. Beam, Brett Adams et al. · Nature · 1990 · 605 citations
Evolutionary origin of inhibitor cystine knot peptides
Shunyi Zhu, Hervé Darbon, Karin Dyason et al. · The FASEB Journal · 2003 · 149 citations
Sonia Aroui, Souhir Brahim, Michel De Waard et al. · Biochemical and Biophysical Research Communications · 2009 · 118 citations